Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter CTLA4 Antikörper

Dieser Maus Monoklonal Antikörper erkennt spezifisch CTLA4 in ELISA und in vivo. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN7543361

Kurzübersicht für Rekombinanter CTLA4 Antikörper (ABIN7543361)

Target

Alle CTLA4 Antikörper anzeigen
CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 140
  • 101
  • 51
  • 14
  • 3
Human

Wirt

  • 85
  • 74
  • 24
  • 9
  • 3
  • 1
  • 1
  • 1
Maus

Klonalität

  • 129
  • 65
  • 3
Monoklonal

Konjugat

  • 92
  • 20
  • 13
  • 12
  • 8
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser CTLA4 Antikörper ist unkonjugiert

Applikation

  • 101
  • 83
  • 64
  • 43
  • 30
  • 29
  • 28
  • 13
  • 10
  • 7
  • 6
  • 6
  • 4
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
ELISA, In vivo Studies (in vivo)

Klon

5E3
  • Verwendungszweck

    Anti-CTLA-4 [5E3], Mouse IgG1, kappa

    Spezifität

    The antibody is specific for CTLA-4. CTLA-4 is a protein receptor that functions as an immune checkpoint and downregulates immune responses.

    Produktmerkmale

    Original Species of Ab: Mouse

    Original Format of Ab: IgG1

    Aufreinigung

    Protein A affinity purified

    Immunogen

    The original antibody was generated by immunizing BALB/c mice with CTLA-4 protein.

    Isotyp

    IgG1 kappa
  • Applikationshinweise

    The specificity of the antibody was confirmed by ELISA analysis. The kinetic parameters of human CTLA-4 protein binding to the antibody were measured and they resulted to be at the sub-nm level. The antitumor activity of the humanized antibody was demonstrated in vivo in animal models. It was proved that the antibody inhibited the tumor in a dose-dependent manner. Mouse PD-1 antibody was combined with the antibody and used to evaluate the toxicity to mice, these experiments compared with the use of Ipilimumab in combination with PD-1 antibody. Results showed that after 5E3 antibody was used in combination with PD-1 antibody, the immunity to the body and the toxicity of heart, liver and lung are significantly lower than the toxicity of Ipilimumab in combination with PD-1 antibody (CN110343180).

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1 mg/mL

    Buffer

    PBS with 0.02 % Proclin 300.

    Konservierungsmittel

    ProClin

    Vorsichtsmaßnahmen

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Target

    CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

    Andere Bezeichnung

    CTLA-4

    Hintergrund

    Cytotoxic T-lymphocyte protein 4, Cytotoxic T-lymphocyte-associated antigen 4, CD152

    UniProt

    P16410

    Pathways

    Cancer Immune Checkpoints
Sie sind hier:
Chat with us!